GlassScriptPhysician profile
Susan R Webb
NPI 1689777690
$1,089.68
in general payments reported to CMS, 2019-2025
18 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $280 · 2022: $247 · 2023: $63.96 · 2024: $371 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.50 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $331.95 | 2021-2024 | Veozah |
| Abbvie INC. | $160.76 | 2021-2024 | |
| Boston Scientific Corporation | $121.98 | 2021-2025 | Watchman Flx, Farapulse, General - Therapies |
| Evofem Biosciences, INC. | $75.48 | 2021-2022 | |
| Exeltis, USA INC. | $56.34 | 2022-2024 | Slynd |
| Ascend Therapeutics US, LLC | $49.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.47 | 2022 | |
| Bausch Health US, LLC | $39.16 | 2024 | Wellbutrin |
| Shockwave Medical, INC | $32.16 | 2025 | |
| Organon LLC | $32.08 | 2021-2023 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $25.29 | 2021 | |
| Mayne Pharma Commercial LLC | $20.66 | 2022 | |
| Nestle Healthcare Nutrition INC. | $20.45 | 2021 | |
| Myriad Genetic Laboratories, INC. | $18.71 | 2024 | Myrisk |
| Therapeuticsmd, INC. | $18.42 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $16.70 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $15.36 | 2021 | |
| Axonics, INC. | $14.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.